Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catney Charles

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|September 15, 2025
Understanding Patient and Physician Perspectives Regarding Innovative Research in Rheumatoid ArthritisMelanie C Baniña, Radhika Prabhune, Catney Charles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Bone Marrow Transplantation|June 10, 2021
Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite scoreNassim Ait Abdallah, Mianbo Wang, Pauline Lansiaux, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Cytotherapy|March 3, 2026
Systemic lupus erythematosus patients eligible for chimeric antigen receptor T-cell therapy according to the 2024 EBMT and International Society for Cell and Gene Therapy expert-based recommendations: a 1-year clinical practice study in FranceMartin Nivet, Ingrid Munia, Benjamin Crichi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|September 15, 2025
Understanding Patient and Physician Perspectives Regarding Innovative Research in Rheumatoid ArthritisMelanie C Baniña, Radhika Prabhune, Catney Charles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Bone Marrow Transplantation|June 10, 2021
Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite scoreNassim Ait Abdallah, Mianbo Wang, Pauline Lansiaux, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Cytotherapy|March 3, 2026
Systemic lupus erythematosus patients eligible for chimeric antigen receptor T-cell therapy according to the 2024 EBMT and International Society for Cell and Gene Therapy expert-based recommendations: a 1-year clinical practice study in FranceMartin Nivet, Ingrid Munia, Benjamin Crichi, et al.
Pageof 1